The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models.
Saved in:
| Title: | The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models. |
|---|---|
| Authors: | Robillard L; Departments of Translational Medicine., Liao M; Clinical Pharmacology, Clovis Oncology Inc., Boulder, CO., Nguyen M; Departments of Translational Medicine., Harding TC; Departments of Translational Medicine., Simmons AD; Departments of Translational Medicine., Dusek RL; Departments of Translational Medicine. |
| Source: | Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2022 Oct 01; Vol. 45 (8), pp. 335-348. Date of Electronic Publication: 2022 Jul 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
